China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
41.88
+0.84 (2.05%)
Mar 14, 2025, 2:45 PM CST
SHE:000999 Revenue
In the year 2024, China Resources Sanjiu Medical & Pharmaceutical had annual revenue of 27.62B CNY with 11.63% growth. China Resources Sanjiu Medical & Pharmaceutical had revenue of 7.88B in the quarter ending December 31, 2024, with 44.21% growth.
Revenue
27.62B
Revenue Growth
+11.63%
P/S Ratio
1.94
Revenue / Employee
1.36M
Employees
20,318
Market Cap
53.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.62B | 2.88B | 11.63% |
Dec 31, 2023 | 24.74B | 6.66B | 36.83% |
Jan 1, 2023 | 18.08B | 2.54B | 16.31% |
Jan 1, 2022 | 15.54B | 1.91B | 13.98% |
Dec 31, 2020 | 13.64B | -1.16B | -7.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |